Attivare licenses Wyss Institute’s immune-modulating biomaterial technology to advance immunotherapies
October 02, 2024 09:30 ET
|
Wyss Institute at Harvard University
Boston, Oct. 02, 2024 (GLOBE NEWSWIRE) -- (BOSTON) — Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Attivare Therapeutics Inc. announced that Attivare has...
Wyss Institute Research Collaboration Awarded ARPA-H Agreement to Develop Disease-Agnostic Immunotherapeutic RNA Platform
July 15, 2024 11:00 ET
|
Wyss Institute at Harvard University
Boston, July 15, 2024 (GLOBE NEWSWIRE) -- With the award for up to $27M from the Advanced Research Projects Agency for Health (ARPA-H), a collaborative research project at the Wyss Institute for...
Circe Bioscience licenses technology to decarbonize industry with microbes developed at Wyss Institute at Harvard University
May 15, 2024 07:00 ET
|
Wyss Institute at Harvard University
Boston, MA, May 15, 2024 (GLOBE NEWSWIRE) -- The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that Circe, a startup developed at the Institute and spun...
Wyss Institute’s AminoX project receives funding from Northpond Labs to accelerate innovation in protein-based therapeutics
April 08, 2024 11:00 ET
|
Wyss Institute at Harvard University
Boston, MA, April 08, 2024 (GLOBE NEWSWIRE) -- The Wyss Institute for Biologically Inspired Engineering at Harvard University and Northpond Ventures announced today that the VC firm’s affiliate...
Harvard’s Wyss Institute and Collaborative Fund cofound research lab to fund technology to combat climate change
May 23, 2023 09:00 ET
|
Wyss Institute at Harvard University
Boston, MA, May 23, 2023 (GLOBE NEWSWIRE) -- Collaborative Fund and the Wyss Institute for Biologically Inspired Engineering at Harvard University are joining forces to launch a research and...
Wyss Institute’s Lab-on-a-Molecule Drug Discovery Project Receives Funding from Northpond Labs
April 04, 2023 09:00 ET
|
Wyss Institute at Harvard University
Boston, April 04, 2023 (GLOBE NEWSWIRE) -- (BOSTON, INSERT DATE) —The Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston Children’s Hospital, and Northpond Labs, the...
Gameto licenses Wyss Institute’s technology for growing human ovaries from Harvard University
February 21, 2023 08:00 ET
|
Wyss Institute at Harvard University
BOSTON, MA, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Despite the fact that we all start out as an egg cell in one of our mother’s ovaries, these human reproductive organs are surprisingly under-studied....
Wyss Institute at Harvard University partners with Northpond Labs to launch RNA solutions company EnPlusOne Biosciences
December 19, 2022 10:14 ET
|
Wyss Institute at Harvard University
Boston, Dec. 19, 2022 (GLOBE NEWSWIRE) -- (BOSTON) — Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and EnPlusOne Biosciences (EnPlusOne Bio) announced that...
Sherlock Biosciences licenses Wyss Institute’s ambient nucleic acid amplification technology from Harvard to develop highly accurate, low-cost diagnostics for point-of-need
October 17, 2022 11:00 ET
|
Wyss Institute at Harvard University
Boston, Oct. 17, 2022 (GLOBE NEWSWIRE) -- (BOSTON) — Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Sherlock Biosciences Inc., announced that Sherlock has...
Unravel Biosciences licenses Wyss Institute platform technology from Harvard and Tufts University to decode, model, and treat complex diseases
September 27, 2022 13:38 ET
|
Wyss Institute at Harvard University
Boston, MA, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Today, Unravel Biosciences and the Wyss Institute for Biologically Inspired Engineering at Harvard University announced that Unravel has licensed a...